Close

Sign in
Sign up

Menu

Intel
Data search
Signals
Startup Concierge
Get intel

Home
News
Solvotrin Therapeutics raises €6.7m in funding from Elkstone Ventures and RAB Capital

Solvotrin Therapeutics raises €6.7m in funding from Elkstone Ventures and RAB Capital

Biotech Health services

Ireland

United Kingdom

Investments

02 November 2020

Share:

Solvotrin Therapeutics (company)

Ireland

Biotech Health services

Total investments received (USD): 7.9m

Round value (USD): 7.9m

Round investors: Elkstone Ventures RAB Capital

Company: Solvotrin Therapeutics

Industry: Biotech Health services

Related deals

ONK Therapeutics announced raising $8 million in a round led by Acorn Bioventures

Biotech Health services

Ireland

United States

Investments 18 October 2020

Sidebar

Verticals

Financial Services
Food Industry
Education
E-commerce
Health services
Marketplace

Benelux

Belgium
Netherlands

DACH

Austria
Germany
Switzerland

Nordics and Baltics

Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden

Western Europe

France
Ireland
Italy
Portugal
Spain
United Kingdom

About
Contact
Terms of service
Privacy policy

© All rights reserved Nordic 9 2016-2026. Made with in Stockholm

Top